DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Daniels GB, Vladic A, Brinar V. et al.
Alemtuzumab-related thyroid dysfunction in a phase 2 trial of patients with relapsing-remitting multiple sclerosis.
J Clin Endocrinol Metabol 2014;
99: 80-89
We do not assume any responsibility for the contents of the web pages of other providers.